Supply of Sterile Occlusive Adhesive Dressings (Tegaderm-Type)

The contract calls for the manufacture or supply of sterile, transparent, adhesive wound dressings designed specifically for use on IV catheters and other wounds, requiring individual packaging and strict compliance with DLA, FDA, and military labeling standards. The dressings must be of a Tegaderm-type design, ensuring occlusive properties, clarity for wound inspection, and reliable adhesion under demanding clinical conditions. All products must meet exacting specifications for sterility, material composition, and performance to ensure safety and effectiveness in military and medical environments. The solicitation, issued under NAICS code 325120, is a subcontract opportunity managed by the Department of Defense’s Medical Supply Chain MD Surg FSF, with performance required at FPO, ZIP 96694. The response deadline is July 27, 2026, and the posting date is July 21, 2026. While no set-aside type is specified, the contract is part of a broader effort to secure critical medical supplies aligned with U.S. military logistics and regulatory frameworks, emphasizing reliability, traceability, and conformity to federal and defense standards.